0000724910 true 0000724910 2006-01-01 2006-01-01

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K/A

(Amendment No. 9)

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)  January 1, 2006

Picture
NVE Corporation
(Exact name of registrant as specified in its charter)

 

Minnesota

000-12196

41-1424202

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

 

11409 Valley View Road, Eden Prairie, Minnesota

55344

(Address of principal executive offices)

(Zip Code)


Registrant’s telephone number, including area code (952) 829-9217

                                                                                                                                
(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
 
Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value

NVEC

The NASDAQ Stock Market, LLC


 

Explanatory Note

This Amendment No. 9 to Form 8-K is being filed to disclose Amendment No. 10 to our Supplier Partnering Agreement dated January 3, 2006 by and between Pacesetter, Inc., now a subsidiary of Abbott Laboratories (“Abbott”), and us, as amended by Amendment No. 1 to the Agreement dated September 6, 2007, Amendment No. 2 dated December 15, 2009, Amendment No. 3 dated September 13, 2010, Amendment No. 4 dated February 1, 2011, Amendment No. 5 dated April 20, 2016, Amendment No. 6 dated December 18, 2020, Amendment No. 7 dated April 30, 2021, Amendment No. 8 dated February 1, 2022, and Amendment No. 9 dated January 20, 2023. Amendment Nos. 1, 2, 3, 6, 7, and 9 were superseded by subsequent amendments.


 

Item 1.01. Entry into a Material Definitive Agreement.

General Information

We supply products to Abbott under the Supplier Partnering Agreement as amended.

Description of the Terms and Conditions of the Amendment

On January 2, 2024, we received a fully-executed Amendment No. 10 to the Supplier Partnering Agreement, which extends the Agreement term through December 31, 2024 and increases pricing for 2024. The Amendment is filed as Exhibit 10.6 to this Current Report on Form 8-K/A.

 

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

Date  January 3, 2024

NVE CORPORATION
(Registrant)


 /s/ DANIEL A. BAKER
Daniel A. Baker
President & Chief Executive Officer

 

 

 

 

 

 

 

3


 

INDEX TO EXHIBITS

 

Exhibit #

Description

  10.1

Indemnification Agreement by and between Pacesetter, Inc., a St. Jude Medical Company, d.b.a. St. Jude Medical Cardiac Rhythm Management Division, and the company (incorporated by reference to the Form 8-K filed September 27, 2005).
 

  10.2+

Supplier Partnering Agreement by and between St. Jude and the company (incorporated by reference to the Form 8-K filed January 4, 2006).
 

  10.3

Amendment No. 4 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed February 7, 2011).
 

  10.4

Amendment No. 5 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed April 21, 2016).
 

  10.5*

Amendment No. 8 to Supplier Partnering Agreement between Abbott and the company (incorporated by reference to the Form 8-K/A filed February 2, 2022).
 

  10.6*

Amendment No. 10 to Supplier Partnering Agreement between Abbott and the company (filed with this Current Report on Form 8-K/A).

 

  104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

+Confidential portions of this exhibit were deleted and filed separately with the SEC under a request for confidential treatment pursuant to Rule 24b-2 or Rule 406.

*Certain confidential portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The omitted information is (i) not material and (ii) would likely cause us competitive harm if publicly disclosed. We agree to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission on its request.

 

 

 

4

 


AMENDMENT NO. 10

TO

SUPPLIER PARTNERING AGREEMENT

 

THIS AMENDMENT TO SUPPLIER PARTNERING AGREEMENT (this “Amendment”), dated as of December 7, 2023, (the “Amendment Effective Date”) is made and entered into by and between Pacesetter, Inc., with offices at 15900 Valley View Court, Sylmar, California, 91342 (“Buyer”), and NVE Corporation, with a principal place of business at 11409 Valley View Rd, Eden Prairie, Minnesota, 55344-3617 (“Seller”).

 

RECITALS

 

A.Buyer and Seller are parties to that certain SUPPLIER PARTNERING AGREEMENT with an effective date of January 1, 2006; Amendment No. 1 with an effective date of September 6, 2007; Amendment No. 2 with an effective date of December 15, 2009; Amendment No. 3 with an effective date of September 13, 2010; Amendment No. 4 with an effective date of February 1, 2011; Amendment No. 5 with an effective date of April 20, 2016; Amendment No. 6 with an effective date of December 16, 2020; Amendment No. 7 with an effective date of April 12, 2021; Amendment No. 8 with an effective date of November 10, 2021; and Amendment No. 9 with an effective date of December 5, 2022 (collectively the “Agreement”). 

 

B.Buyer and Seller now wish to amend the terms of Agreement as set forth in this Amendment. 

 

NOW, THEREFORE, Buyer and Seller agree to amend the Agreement as follows:

 

1. Section 1, Term of Agreement, is hereby deleted and replaced with the following 

 

1. Term of Agreement. This Agreement begins on January 1, 2006 and will remain in force through December 31, 2024, unless terminated earlier. 

 

2. Attachment 1 is hereby amended to reflect a 2024 price of the following: 

Part Number 1071000-001 increase from current price of $** to $**; Part Number 100101124 increase from current price of $** to $** and Part Number 100127071 increase from current price of $** to $**. These increases are effective with all shipments made after December 31, 2023.

 

3.If any provisions of this Amendment and the Agreement conflict, the provisions of this Amendment shall prevail. Except as specifically amended herein, all terms and conditions of the Agreement shall remain in full force and effect. 

 

4. Each party represents that it has authority to enter into this Amendment. This Amendment may be executed in counterparts, each of which for all purposes shall be deemed an original, and all of which constitute, collectively, one agreement. Facsimile or electronically transmitted signatures shall be deemed effective as originals. 

 

The parties have caused this Amendment to be signed by their duly authorized representatives, effective as of the Amendment Effective Date.


9025.3 – NVE Corporation - Supply (Direct) Amended                                                                               Page 1 of 2



Pacesetter, Inc.

 

 

 

By: /s/ Jonathan Harrington                            

 

 

Name: Jonathan Harrington                            

 

 

Title: DVP OPERATIONS+SUPPLY CHAIN

 

 

Date: 15 December 2023                                  

NVE Corporation

 

 

 

By:  /s/ D. Baker                                             

 

 

Name:  Daniel A. Baker                                 

 

 

Title:  President & CEO                                 

 

 

Date:  12/7/23                                                 


9025.3 – NVE Corporation - Supply (Direct) Amended                                                                               Page 2 of 2

v3.23.4
Document and Entity Information
Jan. 01, 2006
Details  
Registrant CIK 0000724910
Document Type 8-K/A
Document Period End Date Jan. 01, 2006
Document Effective Date Jan. 01, 2006
Entity Registrant Name NVE Corp
Entity Incorporation, State or Country Code MN
Entity File Number 000-12196
Entity Tax Identification Number 41-1424202
Entity Address, Address Line One 11409 Valley View Road
Entity Address, City or Town Eden Prairie
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55344
Entity Address, Address Description Address of principal executive offices
Phone Fax Number Description Registrant’s telephone number, including area code
City Area Code 952
Local Phone Number 829-9217
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Title of 12(b) Security Common Stock, $0.01 par value
Trading Symbol NVEC
Security Exchange Name NASDAQ
Amendment Description to disclose Amendment No. 10 to our Supplier Partnering Agreement dated January 3, 2006
Amendment Flag true

NVE (NASDAQ:NVEC)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more NVE Charts.